SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 36.94 |
| Enterprise Value ($M) | -12.48 |
| Book Value ($M) | 118.62 |
| Book Value / Share | 3.63 |
| Price / Book | 0.31 |
| NCAV ($M) | 91.50 |
| NCAV / Share | 2.80 |
| Price / NCAV | 0.40 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.66 |
| Return on Assets (ROA) | -0.43 |
| Return on Equity (ROE) | -0.50 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.41 |
| Current Ratio | 7.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 123.76 |
| Assets | 150.88 |
| Liabilities | 32.26 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -97.74 |
| Net Income | -89.98 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -82.37 |
| Cash from Investing | -37.67 |
| Cash from Financing | 88.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Point72 Asset Management, L.P. | 5.70 | ||
| 13G/A | Janus Henderson Group Plc | 1.60 | -77.65 | |
| 13G | Rtw Investments, Lp | 9.80 | ||
| 13G | Suvretta Capital Management, Llc | 5.10 | 0.00 | |
| 13G/A | Viking Global Investors Lp | 4.50 | 0.00 | |
| 13G/A | Qatar Investment Authority | 3.82 | 0.00 | |
| 13G | Oxford Science Enterprises plc | 14.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 57,551 | 214,995 | 26.77 | |
| 29,136 | 137,033 | 21.26 | |
| 29,648 | 154,448 | 19.20 | |
| 95,420 | 316,670 | 30.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PBYI – Puma Biotechnology, Inc. | PCRX – Pacira BioSciences, Inc. |
| PCVX – Vaxcyte, Inc. | PGEN – Precigen, Inc. |
| PHAT – Phathom Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io